The Implications of the Latest Data on SGLT2 Inhibitors in Heart Failure: A Unified Approach to Treatment?

Drs Zieroth and Anker discuss heart failure (HF) outcome trials with sodium-glucose cotransporter-2 (SGLT2) inhibitors. Credit available for this activity expires: 5/17/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/972924?src=mkm_podcast_addon_972924